These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 830773)

  • 101. Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein.
    Kerbiriou DM; Bouma BN; Griffin JH
    J Biol Chem; 1980 May; 255(9):3952-8. PubMed ID: 6154706
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Assay of factors of the kinin system in plasma from patients with specific exogenous allergies.
    Briseid K; Qvigstad EK; Engelstad M; Lagerlov P; Lange-Nielsen F
    Acta Allergol; 1976 Aug; 31(4):297-311. PubMed ID: 1086050
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Activation of the Hageman factor-prekallikrein system in the pathogenesis of the generalized Shwartzman reaction and of the hepatic vein thrombosis phenomenon in the rat.
    Latour JG; Groulx C; Léger-Gauthier C
    Lab Invest; 1979 Sep; 41(3):237-46. PubMed ID: 470342
    [No Abstract]   [Full Text] [Related]  

  • 104. Evidence that Fitzgerald factor counteracts inhibition by kaolin or ellagic acid of the amidolytic properties of a plasma kallikrein.
    Ratnoff OD; Saito H
    Blood; 1976 Feb; 47(2):243-51. PubMed ID: 1244922
    [TBL] [Abstract][Full Text] [Related]  

  • 105. In vitro assay for prekallikrein activator (PKA).
    Lundblad JL
    Dev Biol Stand; 1979; 44():107-14. PubMed ID: 317466
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Kallikrein-kinin system in severe experimental hypertension.
    Quadra JA; Bossolan D; Stella RC; Ribeiro AB; Kohlmann O; Ramos OL
    Adv Exp Med Biol; 1986; 198 Pt B():313-9. PubMed ID: 3643729
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Role of Hageman factor/kallikrein-kinin system in pseudomonal elastase-induced shock model.
    Khan MM; Yamamoto T; Araki H; Shibuya Y; Kambara T
    Biochim Biophys Acta; 1993 Jun; 1157(2):119-26. PubMed ID: 8507648
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Dextran-induced lowering of prekallikrein proactivator and prekallikrein in rat plasma.
    Briseid G; Briseid K; Toverud EL; Kristoffersen J
    Acta Pharmacol Toxicol (Copenh); 1978 Feb; 42(2):93-102. PubMed ID: 580160
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Changes in plasma levels of prekallikrein, kallikrein, high molecular weight kininogen and kallikrein inhibitors during lethal endotoxin shock in dogs.
    Gallimore MJ; Aasen AO; Amundsen E
    Haemostasis; 1978; 7(2-3):79-84. PubMed ID: 658781
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Tachibana trait: human high molecular weight kininogen deficiency with diminished levels of prekallikrein and low molecular weight kininogen.
    Nakamura K; Iijima K; Fukuda C; Kadowaki H; Ikoma H; Oh-ishi S; Uchida Y; Katori M
    Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1473-9. PubMed ID: 3853954
    [No Abstract]   [Full Text] [Related]  

  • 111. A new prekallikrein activator in human plasma which differs from Hageman factor and its fragments.
    Webster ME; Stella RC; Villa ML; Toffoletto O
    Adv Exp Med Biol; 1979; 120B():53-9. PubMed ID: 517247
    [No Abstract]   [Full Text] [Related]  

  • 112. Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease.
    Matsumoto K; Yamamoto T; Kamata R; Maeda H
    J Biochem; 1984 Sep; 96(3):739-49. PubMed ID: 6438075
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Generation of an esterolytic and kinin-forming kallikrein-alpha2-macroglobulin complex in human serum by treatment with acetone.
    Vogt V; Dugal B
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jul; 294(1):75-84. PubMed ID: 63921
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma.
    Kerbiriou DM; Griffin JH
    J Biol Chem; 1979 Dec; 254(23):12020-7. PubMed ID: 500690
    [TBL] [Abstract][Full Text] [Related]  

  • 115. The role of HF cofactor in the Hageman factor-dependent fibrinolytic mechanism.
    Iatridis PG; Gadarowski JJ; Iatridis SG
    Acta Haematol; 1981; 66(4):257-63. PubMed ID: 6800192
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Contact activation of plasma: structure-activity relationships of human high molecular weight kininogen.
    Kerbiriou D; Griffin JH
    Adv Exp Med Biol; 1979; 120B():153-61. PubMed ID: 517232
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Effect of kininogen on the activity of the kallikreinogen-kallikrein system of human blood serum.
    Yarovaya GA; Dotsenko VL; Orekhovich VN
    Clin Chim Acta; 1977 Jul; 78(1):85-9. PubMed ID: 884851
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Identification of the binding site for plasma prekallikrein in human high molecular weight kininogen. A region from residues 185 to 224 of the kininogen light chain retains full binding activity.
    Tait JF; Fujikawa K
    J Biol Chem; 1986 Nov; 261(33):15396-401. PubMed ID: 3096985
    [TBL] [Abstract][Full Text] [Related]  

  • 119. [Factor XII deficiency - Hageman trait. Additional diagnostic procedures].
    Martinić P
    Bilt Hematol Transfuz; 1979; 7(2-3):151-8. PubMed ID: 263755
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus.
    Kalter ES; van Dijk WC; Timmerman A; Verhoef J; Bouma BN
    J Infect Dis; 1983 Oct; 148(4):682-91. PubMed ID: 6355312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.